Biodesix Inc. (BDSX) Tops Q1 EPS by 1c ; Offers Guidance

Biodesix Inc. (NASDAQ: BDSX) reported Q1 EPS of ($0.14), $0.01 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $14.8 million versus the consensus estimate of $14.17 million.

GUIDANCE:

Biodesix Inc. sees FY2024 revenue of $65-68 million, versus the consensus of $66.17 million.

For earnings history and earnings-related data on Biodesix Inc. (BDSX) click here.

You May Also Be Interested In

• McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
• Pelthos Therapeutics Inc. (PTHS) Misses Q2 EPS by 611c
• Wolverine World Wide (WWW) Tops Q2 EPS by 2c; offers guidance